← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2010Last known activity
Dec 1, 2025
Timeline
2000s
- Jan 1, 2001
Borstkanker Onderzoek Groep— Founded
Drugs by trial phase (24 distinct, 13 trials)
Phase 3 (17 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (21)
- NCT07237256CollaboratorPhase 3Dec 1, 2025
- NCT05392608Lead sponsorPhase 2Jun 2, 2022
- NCT05392608CollaboratorPhase 2Jun 2, 2022
- NCT04489173Lead sponsorPhase 2Jul 31, 2020
- NCT04489173CollaboratorPhase 2Jul 31, 2020
- NCT04489173Study directorPhase 2Jul 31, 2020
- NCT04125277CollaboratorN/ANov 30, 2019
- NCT03820063CollaboratorPhase 2Feb 27, 2019
- NCT03820063Lead sponsorPhase 2Feb 27, 2019
- NCT03820063Study directorPhase 2Feb 27, 2019
- NCT03283384OfficialPhase 2May 31, 2018
- NCT03283384Lead sponsorPhase 2May 31, 2018
- NCT03532087Lead sponsorPhase 2May 31, 2018
- NCT03283384Study directorPhase 2May 31, 2018
- NCT03425838Lead sponsorPhase 3Nov 9, 2017
Details
- Founded
- Amsterdam, NL Jan 1, 2001
- Last known activity
- Dec 1, 2025